Filing Details
- Accession Number:
- 0000014272-14-000267
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-12-05 17:39:48
- Reporting Period:
- 2014-12-05
- Filing Date:
- 2014-12-05
- Accepted Time:
- 2014-12-05 17:39:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
14272 | Bristol Myers Squibb Co | BMY | Pharmaceutical Preparations (2834) | 220790350 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1208099 | Lamberto Andreotti | Bristol-Myers Squibb Company 345 Park Avenue New York NY 10154 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.10 Par Value | Disposition | 2014-12-05 | 9,696 | $59.21 | 426,113 | No | 4 | S | Direct | |
Common Stock, $0.10 Par Value | Disposition | 2014-12-05 | 65,004 | $60.47 | 361,109 | No | 4 | S | Direct | |
Common Stock, $0.10 Par Value | Disposition | 2014-12-05 | 300 | $60.84 | 360,809 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 28, 2014.
- The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $58.84 to $59.8329, inclusive.
- The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $59.84 to $60.83, inclusive.
- The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $60.84 to $60.85, inclusive.